NCT00131963View on ClinicalTrials.gov

A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

Given IV

DRUG

doxorubicin

Given IV

DRUG

paclitaxel

Given IV

Trial Locations (1)

27710

Duke Cancer Institute, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER